3 articles
People with asthma and chronic obstructive pulmonary disease (COPD) who take the GLP-1 receptor agonist semaglutide appear to suffer significantly fewer acute respiratory attacks, according...
Millions of Seniors Gain Access to Affordable Weight-Loss Medications In a historic shift in public health policy, Medicare has officially begun covering GLP-1 weight-loss drugs...
A major new study involving more than 110,000 women has found that popular GLP-1 weight-loss and diabetes drugs — including Ozempic, Wegovy, Mounjaro, and Zepbound...